AKBA (Akebia Therapeutics, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 48.85 million USD with EPS (earnings per share) anticipated at (0.04) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported62.47 M58.77 M57.62 M53.54 M— | Revenue Estimate47.24 M58.23 M46.09 M51.67 M48.85 M | Revenue Surprise+32.23%+0.92%+25.01%+3.63% | EPS Reported0.000.00(0.05)(0.03) | EPS Estimate(0.02)(0.01)(0.04)(0.03)(0.04) | EPS Surprise+100.00%+100.00%-38.89%-7.14% |